These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2066075)

  • 1. Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
    Ariza J; Xiol X; Esteve M; Fernández Bañeres F; Liñares J; Alonso T; Gudiol F
    Hepatology; 1991 Jul; 14(1):91-8. PubMed ID: 2066075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis.
    Ariza J; Gudiol F; Dolz C; Xiol J; Liñares J; Bosch J; Pallares R
    Hepatology; 1986; 6(5):906-10. PubMed ID: 3530945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.
    Kaymakoglu S; Eraksoy H; Okten A; Demir K; Calangu S; Cakaloglu Y; Boztas G; Besisik F
    Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):71-6. PubMed ID: 9031903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study.
    Rimola A; Salmerón JM; Clemente G; Rodrigo L; Obrador A; Miranda ML; Guarner C; Planas R; Solá R; Vargas V
    Hepatology; 1995 Mar; 21(3):674-9. PubMed ID: 7875666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
    Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
    J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.
    Abd Elaal MM; Zaghloul SG; Bakr HG; Ashour MA; Abdel-Aziz-El-Hady H; Khalifa NA; Amr GE
    Arab J Gastroenterol; 2012 Jun; 13(2):65-70. PubMed ID: 22980594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.
    Badawy AA; Zaher TI; Sharaf SM; Emara MH; Shaheen NE; Aly TF
    World J Gastroenterol; 2013 Feb; 19(8):1271-7. PubMed ID: 23483064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.
    Arroyo V; Navasa M; Rimola A
    Infection; 1994; 22 Suppl 3():S167-75. PubMed ID: 7843826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.
    Angeloni S; Leboffe C; Parente A; Venditti M; Giordano A; Merli M; Riggio O
    World J Gastroenterol; 2008 May; 14(17):2757-62. PubMed ID: 18461661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial peritonitis in cirrhosis. Prospective study of 80 episodes].
    Gómez-Jiménez J; Ribera E; Martínez-Vázquez JM; Gasser I; Segura RM
    Med Clin (Barc); 1992 Oct; 99(13):493-7. PubMed ID: 1434973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
    Ricart E; Soriano G; Novella MT; Ortiz J; Sàbat M; Kolle L; Sola-Vera J; Miñana J; Dedéu JM; Gómez C; Barrio JL; Guarner C
    J Hepatol; 2000 Apr; 32(4):596-602. PubMed ID: 10782908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.
    Toledo C; Salmerón JM; Rimola A; Navasa M; Arroyo V; Llach J; Ginès A; Ginès P; Rodés J
    Hepatology; 1993 Feb; 17(2):251-7. PubMed ID: 8428722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
    Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
    Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Ljubicic N; Spajic D; Vrkljan MM; Altabas V; Doko M; Zovak M; Gacina P; Mihatov S
    Hepatogastroenterology; 2000; 47(35):1360-3. PubMed ID: 11100352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
    Soriano F; Ponte C; Santamaría M; Castilla C
    J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis.
    Runyon BA; Akriviadis EA; Sattler FR; Cohen J
    Dig Dis Sci; 1991 Dec; 36(12):1782-6. PubMed ID: 1748049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.
    Rimola A; Navasa M; Arroyo V
    Diagn Microbiol Infect Dis; 1995; 22(1-2):141-5. PubMed ID: 7587029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous bacterial peritonitis].
    Skladaný Ľ; Kasová S; Purgelová A; Bystrianska N; Adamcová-Selčanová S
    Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.